OBJECTIVES: To find whether CSF analysis may differentiate between relapsing-remitting and secondary progressive multiple sclerosis. METHODS: In 17 patients with relapsing-remitting and 16 patients with secondary progressive multiple sclerosis, all without current or recent relapses, albumin CSF: peripheral blood ratio, mononuclear cell number, CD4+, CD8+, and B1+ subsets, CD4+:CD8+ ratio, IgG, IgG index, IgM, IgM index, complement components C3 and C4, and C3 and C4 indices, myelin basic protein, neuron specific enolase, S100, and lactate were determined. For each measure the statistical distance measure D2 was calculated. For computation of a discriminant score variables with a P value< or =0.15 were included (two sided univariate t test). These were albumin CSF: peripheral blood ratio, mononuclear cell number, IgM, IgM index, C3, C4, neuron specific enolase, S100, and lactate. Simultaneous distributions of the variables were compared between both groups (multivariate t test) and a discriminant score was computed (linear discriminant analysis). RESULTS: The discriminant score allocated all 14 relapsing-remitting patients to the relapsing-remitting group (positive score) and 12 of 13 secondary progressive patients to the secondary progressive group (negative score). One secondary progressive patient was allocated to the relapsing-remitting group. CONCLUSIONS: Patients with relapsing-remitting or secondary progressive multiple sclerosis differ in CSF profile and CSF analysis may help to differentiate between relapsing-remitting and secondary progressive multiple sclerosis.
OBJECTIVES: To find whether CSF analysis may differentiate between relapsing-remitting and secondary progressive multiple sclerosis. METHODS: In 17 patients with relapsing-remitting and 16 patients with secondary progressive multiple sclerosis, all without current or recent relapses, albumin CSF: peripheral blood ratio, mononuclear cell number, CD4+, CD8+, and B1+ subsets, CD4+:CD8+ ratio, IgG, IgG index, IgM, IgM index, complement components C3 and C4, and C3 and C4 indices, myelin basic protein, neuron specific enolase, S100, and lactate were determined. For each measure the statistical distance measure D2 was calculated. For computation of a discriminant score variables with a P value< or =0.15 were included (two sided univariate t test). These were albumin CSF: peripheral blood ratio, mononuclear cell number, IgM, IgM index, C3, C4, neuron specific enolase, S100, and lactate. Simultaneous distributions of the variables were compared between both groups (multivariate t test) and a discriminant score was computed (linear discriminant analysis). RESULTS: The discriminant score allocated all 14 relapsing-remitting patients to the relapsing-remitting group (positive score) and 12 of 13 secondary progressive patients to the secondary progressive group (negative score). One secondary progressive patient was allocated to the relapsing-remitting group. CONCLUSIONS:Patients with relapsing-remitting or secondary progressive multiple sclerosis differ in CSF profile and CSF analysis may help to differentiate between relapsing-remitting and secondary progressive multiple sclerosis.
Authors: M B Bornstein; A Miller; S Slagle; M Weitzman; E Drexler; M Keilson; V Spada; W Weiss; S Appel; L Rolak Journal: Neurology Date: 1991-04 Impact factor: 9.910
Authors: William T Regenold; Pornima Phatak; Michael J Makley; Roger D Stone; Mitchel A Kling Journal: J Neurol Sci Date: 2008-09-09 Impact factor: 3.181
Authors: Andrew A Kanner; Nicola Marchi; Vincent Fazio; Marc R Mayberg; Michael T Koltz; Vitaly Siomin; Glen H J Stevens; Thomas Masaryk; Barbara Aumayr; Barbara Ayumar; Michael A Vogelbaum; Gene H Barnett; Damir Janigro Journal: Cancer Date: 2003-06-01 Impact factor: 6.860
Authors: J R Infante; A Martínez; J Ochoa; F Cañadillas; M Torres-Avisbal; J A Vallejo; F M González; C Pacheco; J M Latre Journal: J Physiol Biochem Date: 2003-12 Impact factor: 4.158
Authors: Sven Jarius; Hannah Pellkofer; Nadja Siebert; Mirjam Korporal-Kuhnke; Martin W Hümmert; Marius Ringelstein; Paulus S Rommer; Ilya Ayzenberg; Klemens Ruprecht; Luisa Klotz; Nasrin Asgari; Tobias Zrzavy; Romana Höftberger; Rafik Tobia; Mathias Buttmann; Kai Fechner; Kathrin Schanda; Martin Weber; Susanna Asseyer; Jürgen Haas; Christian Lechner; Ingo Kleiter; Orhan Aktas; Corinna Trebst; Kevin Rostasy; Markus Reindl; Tania Kümpfel; Friedemann Paul; Brigitte Wildemann Journal: J Neuroinflammation Date: 2020-09-03 Impact factor: 8.322
Authors: Sven Jarius; Christian Lechner; Eva M Wendel; Matthias Baumann; Markus Breu; Mareike Schimmel; Michael Karenfort; Adela Della Marina; Andreas Merkenschlager; Charlotte Thiels; Astrid Blaschek; Michela Salandin; Steffen Leiz; Frank Leypoldt; Alexander Pschibul; Annette Hackenberg; Andreas Hahn; Steffen Syrbe; Jurgis Strautmanis; Martin Häusler; Peter Krieg; Astrid Eisenkölbl; Johannes Stoffels; Matthias Eckenweiler; Ilya Ayzenberg; Jürgen Haas; Romana Höftberger; Ingo Kleiter; Mirjam Korporal-Kuhnke; Marius Ringelstein; Klemens Ruprecht; Nadja Siebert; Kathrin Schanda; Orhan Aktas; Friedemann Paul; Markus Reindl; Brigitte Wildemann; Kevin Rostásy Journal: J Neuroinflammation Date: 2020-09-03 Impact factor: 8.322